Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-03 Davis Hugh M. President and COO Exercise or conversion +18,675 45,425
2026-02-03 Davis Hugh M. President and COO Exercise or conversion · Restricted Stock Units −18,675 56,025
2026-02-02 Davis Hugh M. President and COO Grant or award · Restricted Stock Units +96,100 96,100
2026-02-02 Davis Hugh M. President and COO Grant or award · Employee Stock Option (Right to Buy) +336,300 336,300
2025-12-02 Davis Hugh M. President and COO Exercise or conversion +26,750 26,750
2025-12-02 Davis Hugh M. President and COO Exercise or conversion · Restricted Stock Units −26,750 80,250
2025-02-03 Davis Hugh M. President and COO Grant or award · Restricted Stock Units +74,700 74,700
2025-02-03 Davis Hugh M. President and COO Grant or award · Employee Stock Option (Right to Buy) +261,600 261,600
2024-12-02 Davis Hugh M. President and COO Grant or award · Employee Stock Option (Right to Buy) +375,000 375,000
2024-12-02 Davis Hugh M. President and COO Grant or award · Restricted Stock Units +107,000 107,000

Page 1 of 1 · 10 trades